世界のラタノプロスト市場予測 2021年-2026年

【英語タイトル】Global Latanoprost Market Growth 2021-2026

LP Informationが出版した調査資料(LPI21JL16206)・商品コード:LPI21JL16206
・発行会社(調査会社):LP Information
・発行日:2021年7月(※2024年版があります。お問い合わせください)
・ページ数:133
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
LPインフォメーション社の「ラタノプロストの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ブランド薬、ジェネリック薬など、用途別には、開放隅角緑内障、閉鎖隅角緑内障などにセグメント区分してまとめました。ラタノプロストのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・ラタノプロストの世界市場概要(サマリー)
・ラタノプロストの企業別販売量・売上
・ラタノプロストの企業別市場シェア
・ラタノプロストの世界市場規模 2016年-2021年:種類別(ブランド薬、ジェネリック薬)
・ラタノプロストの世界市場規模 2016年-2021年:用途別(開放隅角緑内障、閉鎖隅角緑内障)
・ラタノプロストの南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・ラタノプロストのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・ラタノプロストのヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ラタノプロストの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・ラタノプロスト市場の成長要因・課題・動向
・ラタノプロストの世界市場予測 2021年-2026年
・ラタノプロストの南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・ラタノプロストのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・ラタノプロストのヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ラタノプロストの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・ラタノプロストの世界市場予測:種類別(ブランド薬、ジェネリック薬)
・ラタノプロストの世界市場予測:用途別(開放隅角緑内障、閉鎖隅角緑内障)
・主要企業分析
【レポートの概要】

According to this latest study, the 2021 growth of Latanoprost will have significant change from previous year. By the most conservative estimates of global Latanoprost market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 1315.4 million in 2020. Over the next five years the Latanoprost market will register a 2.3% CAGR in terms of revenue, the global market size will reach US$ 1439.6 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Latanoprost market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Brand Drug
Generic Drug

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Open-angle Glaucoma
Close-angle Glaucoma

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Pfizer
Mylan
Novartis
Apotex
Teva
Taj Pharma
CR Zizhu

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Latanoprost Consumption 2016-2026
2.1.2 Latanoprost Consumption CAGR by Region
2.2 Latanoprost Segment by Type
2.2.1 Brand Drug
2.2.2 Generic Drug
2.3 Latanoprost Sales by Type
2.3.1 Global Latanoprost Sales Market Share by Type (2016-2021)
2.3.2 Global Latanoprost Revenue and Market Share by Type (2016-2021)
2.3.3 Global Latanoprost Sale Price by Type (2016-2021)
2.4 Latanoprost Segment by Application
2.4.1 Open-angle Glaucoma
2.4.2 Close-angle Glaucoma
2.5 Latanoprost Sales by Application
2.5.1 Global Latanoprost Sale Market Share by Application (2016-2021)
2.5.2 Global Latanoprost Revenue and Market Share by Application (2016-2021)
2.5.3 Global Latanoprost Sale Price by Application (2016-2021)

3 Global Latanoprost by Company
3.1 Global Latanoprost Sales Market Share by Company
3.1.1 Global Latanoprost Sales by Company (2019-2021)
3.1.2 Global Latanoprost Sales Market Share by Company (2019-2021)
3.2 Global Latanoprost Revenue Market Share by Company
3.2.1 Global Latanoprost Revenue by Company (2019-2021)
3.2.2 Global Latanoprost Revenue Market Share by Company (2019-2021)
3.3 Global Latanoprost Sale Price by Company
3.4 Global Manufacturers Latanoprost Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Latanoprost Product Location Distribution
3.4.2 Players Latanoprost Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Latanoprost by Region
4.1 Global Latanoprost by Region
4.1.1 Global Latanoprost Sales by Region
4.1.2 Global Latanoprost Revenue by Region
4.2 Americas Latanoprost Sales Growth
4.3 APAC Latanoprost Sales Growth
4.4 Europe Latanoprost Sales Growth
4.5 Middle East & Africa Latanoprost Sales Growth

5 Americas
5.1 Americas Latanoprost Sales by Country
5.1.1 Americas Latanoprost Sales by Country (2016-2021)
5.1.2 Americas Latanoprost Revenue by Country (2016-2021)
5.2 Americas Latanoprost Sales by Type
5.3 Americas Latanoprost Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Latanoprost Sales by Region
6.1.1 APAC Latanoprost Sales by Region (2016-2021)
6.1.2 APAC Latanoprost Revenue by Region (2016-2021)
6.2 APAC Latanoprost Sales by Type
6.3 APAC Latanoprost Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Latanoprost by Country
7.1.1 Europe Latanoprost Sales by Country (2016-2021)
7.1.2 Europe Latanoprost Revenue by Country (2016-2021)
7.2 Europe Latanoprost Sales by Type
7.3 Europe Latanoprost Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Latanoprost by Country
8.1.1 Middle East & Africa Latanoprost Sales by Country (2016-2021)
8.1.2 Middle East & Africa Latanoprost Revenue by Country (2016-2021)
8.2 Middle East & Africa Latanoprost Sales by Type
8.3 Middle East & Africa Latanoprost Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Latanoprost Distributors
10.3 Latanoprost Customer

11 Global Latanoprost Market Forecast
11.1 Global Latanoprost Forecast by Region
11.1.1 Global Latanoprost Forecast by Regions (2021-2026)
11.2.2 Global Latanoprost Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Latanoprost Forecast by Type
11.7 Global Latanoprost Forecast by Application

12 Key Players Analysis
12.1 Pfizer
12.1.1 Pfizer Company Information
12.1.2 Pfizer Latanoprost Product Offered
12.1.3 Pfizer Latanoprost Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Pfizer Main Business Overview
12.1.5 Pfizer Latest Developments
12.2 Mylan
12.2.1 Mylan Company Information
12.2.2 Mylan Latanoprost Product Offered
12.2.3 Mylan Latanoprost Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Mylan Main Business Overview
12.2.5 Mylan Latest Developments
12.3 Novartis
12.3.1 Novartis Company Information
12.3.2 Novartis Latanoprost Product Offered
12.3.3 Novartis Latanoprost Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Novartis Main Business Overview
12.3.5 Novartis Latest Developments
12.4 Apotex
12.4.1 Apotex Company Information
12.4.2 Apotex Latanoprost Product Offered
12.4.3 Apotex Latanoprost Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Apotex Main Business Overview
12.4.5 Apotex Latest Developments
12.5 Teva
12.5.1 Teva Company Information
12.5.2 Teva Latanoprost Product Offered
12.5.3 Teva Latanoprost Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Teva Main Business Overview
12.5.5 Teva Latest Developments
12.6 Taj Pharma
12.6.1 Taj Pharma Company Information
12.6.2 Taj Pharma Latanoprost Product Offered
12.6.3 Taj Pharma Latanoprost Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Taj Pharma Main Business Overview
12.6.5 Taj Pharma Latest Developments
12.7 CR Zizhu
12.7.1 CR Zizhu Company Information
12.7.2 CR Zizhu Latanoprost Product Offered
12.7.3 CR Zizhu Latanoprost Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 CR Zizhu Main Business Overview
12.7.5 CR Zizhu Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Latanoprost Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Brand Drug
Table 3. Major Players of Generic Drug
Table 4. Global Latanoprost Sales by Type (2016-2021) & (M Unit)
Table 5. Global Latanoprost Sales Market Share by Type (2016-2021)
Table 6. Global Latanoprost Revenue by Type (2016-2021) & ($ million)
Table 7. Global Latanoprost Revenue Market Share by Type (2016-2021)
Table 8. Global Latanoprost Sale Price by Type (2016-2021)
Table 9. Global Latanoprost Sales by Application (2016-2021) & (M Unit)
Table 10. Global Latanoprost Sales Market Share by Application (2016-2021)
Table 11. Global Latanoprost Value by Application (2016-2021)
Table 12. Global Latanoprost Revenue Market Share by Application (2016-2021)
Table 13. Global Latanoprost Sale Price by Application (2016-2021)
Table 14. Global Latanoprost Sales by Company (2019-2021) & (M Unit)
Table 15. Global Latanoprost Sales Market Share by Company (2019-2021)
Table 16. Global Latanoprost Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Latanoprost Revenue Market Share by Company (2019-2021)
Table 18. Global Latanoprost Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Latanoprost Producing Area Distribution and Sales Area
Table 20. Players Latanoprost Products Offered
Table 21. Latanoprost Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Latanoprost Sales by Region (2016-2021) (M Unit)
Table 25. Global Latanoprost Sales Market Share by Region (2016-2021)
Table 26. Global Latanoprost Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Latanoprost Revenue Market Share by Region (2016-2021)
Table 28. Americas Latanoprost Sales by Country (2016-2021) & (M Unit)
Table 29. Americas Latanoprost Sales Market Share by Country (2016-2021)
Table 30. Americas Latanoprost Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Latanoprost Revenue Market Share by Country (2016-2021)
Table 32. Americas Latanoprost Sales by Type (2016-2021) & (M Unit)
Table 33. Americas Latanoprost Sales Market Share by Type (2016-2021)
Table 34. Americas Latanoprost Sales by Application (2016-2021) & (M Unit)
Table 35. Americas Latanoprost Sales Market Share by Application (2016-2021)
Table 36. APAC Latanoprost Sales by Region (2016-2021) & (M Unit)
Table 37. APAC Latanoprost Sales Market Share by Region (2016-2021)
Table 38. APAC Latanoprost Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Latanoprost Revenue Market Share by Region (2016-2021)
Table 40. APAC Latanoprost Sales by Type (2016-2021) & (M Unit)
Table 41. APAC Latanoprost Sales Market Share by Type (2016-2021)
Table 42. APAC Latanoprost Sales by Application (2016-2021) & (M Unit)
Table 43. APAC Latanoprost Sales Market Share by Application (2016-2021)
Table 44. Europe Latanoprost Sales by Country (2016-2021) & (M Unit)
Table 45. Europe Latanoprost Sales Market Share by Country (2016-2021)
Table 46. Europe Latanoprost Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Latanoprost Revenue Market Share by Country (2016-2021)
Table 48. Europe Latanoprost Sales by Type (2016-2021) & (M Unit)
Table 49. Europe Latanoprost Sales Market Share by Type (2016-2021)
Table 50. Europe Latanoprost Sales by Application (2016-2021) & (M Unit)
Table 51. Europe Latanoprost Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Latanoprost Sales by Country (2016-2021) & (M Unit)
Table 53. Middle East & Africa Latanoprost Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Latanoprost Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Latanoprost Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Latanoprost Sales by Type (2016-2021) & (M Unit)
Table 57. Middle East & Africa Latanoprost Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Latanoprost Sales by Application (2016-2021) & (M Unit)
Table 59. Middle East & Africa Latanoprost Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Latanoprost
Table 61. Key Application and Potential Industries of Latanoprost
Table 62. Key Challenges of Latanoprost
Table 63. Key Trends of Latanoprost
Table 64. Latanoprost Distributors List
Table 65. Latanoprost Customer List
Table 66. Global Latanoprost Sales Forecast by Region (2021-2026) & (M Unit)
Table 67. Global Latanoprost Consumption Market Forecast by Region
Table 68. Global Latanoprost Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Latanoprost Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Latanoprost Sales Forecast by Country (2021-2026) & (M Unit)
Table 71. Americas Latanoprost Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Latanoprost Sales Forecast by Region (2021-2026) & (M Unit)
Table 73. APAC Latanoprost Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Latanoprost Sales Forecast by Country (2021-2026) & (M Unit)
Table 75. Europe Latanoprost Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Latanoprost Sales Forecast by Country (2021-2026) & (M Unit)
Table 77. Middle East & Africa Latanoprost Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Latanoprost Sales Forecast by Type (2021-2026) & (M Unit)
Table 79. Global Latanoprost Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Latanoprost Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Latanoprost Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Latanoprost Sales Forecast by Application (2021-2026) & (M Unit)
Table 83. Global Latanoprost Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Latanoprost Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Latanoprost Revenue Market Share Forecast by Application (2021-2026)
Table 86. Pfizer Basic Information, Latanoprost Manufacturing Base, Sales Area and Its Competitors
Table 87. Pfizer Latanoprost Product Offered
Table 88. Pfizer Latanoprost Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 89. Pfizer Main Business
Table 90. Pfizer Latest Developments
Table 91. Mylan Basic Information, Latanoprost Manufacturing Base, Sales Area and Its Competitors
Table 92. Mylan Latanoprost Product Offered
Table 93. Mylan Latanoprost Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 94. Mylan Main Business
Table 95. Mylan Latest Developments
Table 96. Novartis Basic Information, Latanoprost Manufacturing Base, Sales Area and Its Competitors
Table 97. Novartis Latanoprost Product Offered
Table 98. Novartis Latanoprost Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 99. Novartis Main Business
Table 100. Novartis Latest Developments
Table 101. Apotex Basic Information, Latanoprost Manufacturing Base, Sales Area and Its Competitors
Table 102. Apotex Latanoprost Product Offered
Table 103. Apotex Latanoprost Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 104. Apotex Main Business
Table 105. Apotex Latest Developments
Table 106. Teva Basic Information, Latanoprost Manufacturing Base, Sales Area and Its Competitors
Table 107. Teva Latanoprost Product Offered
Table 108. Teva Latanoprost Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 109. Teva Main Business
Table 110. Teva Latest Developments
Table 111. Taj Pharma Basic Information, Latanoprost Manufacturing Base, Sales Area and Its Competitors
Table 112. Taj Pharma Latanoprost Product Offered
Table 113. Taj Pharma Latanoprost Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 114. Taj Pharma Main Business
Table 115. Taj Pharma Latest Developments
Table 116. CR Zizhu Basic Information, Latanoprost Manufacturing Base, Sales Area and Its Competitors
Table 117. CR Zizhu Latanoprost Product Offered
Table 118. CR Zizhu Latanoprost Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 119. CR Zizhu Main Business
Table 120. CR Zizhu Latest Developments
List of Figures
Figure 1. Picture of Latanoprost
Figure 2. Latanoprost Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Latanoprost Sales Growth Rate 2016-2026 (M Unit)
Figure 7. Global Latanoprost Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Latanoprost Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Brand Drug
Figure 10. Product Picture of Generic Drug
Figure 11. Global Latanoprost Sales Market Share by Type in 2020
Figure 12. Global Latanoprost Revenue Market Share by Type (2016-2021)
Figure 13. Latanoprost Consumed in Open-angle Glaucoma
Figure 14. Global Latanoprost Market: Open-angle Glaucoma (2016-2021) & (M Unit)
Figure 15. Latanoprost Consumed in Close-angle Glaucoma
Figure 16. Global Latanoprost Market: Close-angle Glaucoma (2016-2021) & (M Unit)
Figure 17. Global Latanoprost Sales Market Share by Application (2016-2021)
Figure 18. Global Latanoprost Revenue Market Share by Application in 2020
Figure 19. Latanoprost Revenue Market by Company in 2020 ($ Million)
Figure 20. Global Latanoprost Revenue Market Share by Company in 2020
Figure 21. Global Latanoprost Sales Market Share by Regions (2016-2021)
Figure 22. Global Latanoprost Revenue Market Share by Region in 2020
Figure 23. Americas Latanoprost Sales 2016-2021 (M Unit)
Figure 24. Americas Latanoprost Revenue 2016-2021 ($ Millions)
Figure 25. APAC Latanoprost Sales 2016-2021 (M Unit)
Figure 26. APAC Latanoprost Revenue 2016-2021 ($ Millions)
Figure 27. Europe Latanoprost Sales 2016-2021 (M Unit)
Figure 28. Europe Latanoprost Revenue 2016-2021 ($ Millions)
Figure 29. Middle East & Africa Latanoprost Sales 2016-2021 (M Unit)
Figure 30. Middle East & Africa Latanoprost Revenue 2016-2021 ($ Millions)
Figure 31. Americas Latanoprost Sales Market Share by Country in 2020
Figure 32. Americas Latanoprost Revenue Market Share by Country in 2020
Figure 33. Americas Latanoprost Sales Market Share by Type in 2020
Figure 34. Americas Latanoprost Sales Market Share by Application in 2020
Figure 35. United States Latanoprost Revenue Growth 2016-2021 ($ Millions)
Figure 36. Canada Latanoprost Revenue Growth 2016-2021 ($ Millions)
Figure 37. Mexico Latanoprost Revenue Growth 2016-2021 ($ Millions)
Figure 38. Brazil Latanoprost Revenue Growth 2016-2021 ($ Millions)
Figure 39. APAC Latanoprost Sales Market Share by Region in 2020
Figure 40. APAC Latanoprost Revenue Market Share by Regions in 2020
Figure 41. APAC Latanoprost Sales Market Share by Type in 2020
Figure 42. APAC Latanoprost Sales Market Share by Application in 2020
Figure 43. China Latanoprost Revenue Growth 2016-2021 ($ Millions)
Figure 44. Japan Latanoprost Revenue Growth 2016-2021 ($ Millions)
Figure 45. Korea Latanoprost Revenue Growth 2016-2021 ($ Millions)
Figure 46. Southeast Asia Latanoprost Revenue Growth 2016-2021 ($ Millions)
Figure 47. India Latanoprost Revenue Growth 2016-2021 ($ Millions)
Figure 48. Australia Latanoprost Revenue Growth 2016-2021 ($ Millions)
Figure 49. Europe Latanoprost Sales Market Share by Country in 2020
Figure 50. Europe Latanoprost Revenue Market Share by Country in 2020
Figure 51. Europe Latanoprost Sales Market Share by Type in 2020
Figure 52. Europe Latanoprost Sales Market Share by Application in 2020
Figure 53. Germany Latanoprost Revenue Growth 2016-2021 ($ Millions)
Figure 54. France Latanoprost Revenue Growth 2016-2021 ($ Millions)
Figure 55. UK Latanoprost Revenue Growth 2016-2021 ($ Millions)
Figure 56. Italy Latanoprost Revenue Growth 2016-2021 ($ Millions)
Figure 57. Russia Latanoprost Revenue Growth 2016-2021 ($ Millions)
Figure 58. Middle East & Africa Latanoprost Sales Market Share by Country in 2020
Figure 59. Middle East & Africa Latanoprost Revenue Market Share by Country in 2020
Figure 60. Middle East & Africa Latanoprost Sales Market Share by Type in 2020
Figure 61. Middle East & Africa Latanoprost Sales Market Share by Application in 2020
Figure 62. Egypt Latanoprost Revenue Growth 2016-2021 ($ Millions)
Figure 63. South Africa Latanoprost Revenue Growth 2016-2021 ($ Millions)
Figure 64. Israel Latanoprost Revenue Growth 2016-2021 ($ Millions)
Figure 65. Turkey Latanoprost Revenue Growth 2016-2021 ($ Millions)
Figure 66. GCC Country Latanoprost Revenue Growth 2016-2021 ($ Millions)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles


★調査レポート[世界のラタノプロスト市場予測 2021年-2026年] (コード:LPI21JL16206)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のラタノプロスト市場予測 2021年-2026年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆